OREANDA-NEWS. Hardman & Co have published a report on Empresaria Group. Empresaria has announced the acquisition of Pharmaceutical Strategies a provider of temporary workers to the US healthcare sector. The business is currently growing strongly and sector growth is expected to continue. The deal has been financed by a share placing which was oversubscribed and by small additional debt facility. The deal should be earnings enhancing in its first full year and the balance sheet remains in a comfortable position. The vendor's CEO has been locked in and the deal meets a number of the group's strategic objectives. It looks a great deal and should boost the company's growth.

For the past 20 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge.  Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.